NCG Key Initiatives

The Molecular Pathology Quality Assurance Program (MPQAP) is designed to achieve uniformity in every aspect of molecular diagnostics right from sample selection to performing the tests to analytical interpretation by offering the Proficiency testing services in Solid tumour Molecular diagnostics.

The MPQAP EQAS follows the Method-based proficiency testing approach that relies on method, rather than based on each individual analyte tested. MBPT approach provides better assessment of proficiency of testing laboratories in identifying false positives and false negatives.

At present, there are several providers for EQA schemes for mutation detection in solid tumors at international level. However at national level challenges have been identified to participate in inter laboratory performance evaluation; such as lack of appropriate samples, availability of control/reference material and exorbitant cost of participation in CAP Accreditation program.

MPQAP PT schemes provides an ideal platform for quality assurance in solid tumour testing and provide reliable and cost effective modules that can support your organization to uphold standards of molecular diagnostic testing.

MP-QAP provides a forum for on-going standardization of molecular pathology services across the country and address critical issues, aims to build national guideline data base. It looks forward to become exemplary accredited PT provider across the country, also extending the services at both national and international level.

Ours is a non-profit scientific organization without economic or political interests. All the protocols provided are as per the standardization carried out at our laboratory. This program is presently being run by National Cancer Grid in the Tata Memorial Hospital premises.